New
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee
Group
Practice Harmonisation and Guidelines Committee
1st listed author
Guillermo Ortí
Journal
Bone Marrow Transplant.